Heart Transplant in India (2026): Cost, Best Hospitals, Success Rate and Ultimate Guide for International Patients

Filters & Insights

Learn about heart transplant in India. Cost from $25,000, top hospitals, 85-90% success rate, donor process & free consultation for international patients.
Heart transplant in India showing advanced cardiac surgery and heart replacement procedure

A heart transplant is the most significant surgery a human being can undergo. It is reserved for patients with end-stage heart failure whose hearts can no longer sustain life with any other treatment. For those patients, a transplant is not a choice. It is the only option left.

India has quietly become one of the world’s most trusted destinations for heart transplantation. With internationally trained cardiac surgeons, JCI and NABH-accredited transplant centres, modern transplant ICUs, and costs that are 60 to 80 percent lower than the USA or UK, India gives international patients access to this life-saving procedure without the financial devastation that comes with it in the West.

According to the Indian Society for Heart and Lung Transplantation registry, India has performed over 1,300 heart transplants to date across more than 70 approved transplant centres. India was recorded as the second highest nation globally for solid organ transplant volume in 2018, behind only the United States. The programme continues to grow year on year, with survival rates at leading centres reaching 85 to 90 percent at one year, fully in line with global benchmarks.

This complete 2026 guide covers everything an international patient needs to know: what a heart transplant involves, who qualifies, how donors are matched, what it costs, which hospitals lead the field, and how Shifam Health connects you to the right team safely and seamlessly.

Quick Summary

Who Needs It: Patients with end-stage heart failure, severe cardiomyopathy, or irreversible cardiac disease

Cost in India: USD 25,000 to USD 45,000 (approx. INR 20 lakh to INR 37 lakh) all-inclusive

vs USA: USD 1,000,000 or more in the USA

vs UK: GBP 100,000 to GBP 200,000 in the UK (private)

Success Rate: 85 to 90 percent survival at one year at leading Indian centres

Surgery Duration: 4 to 8 hours

Hospital Stay: 3 to 5 weeks minimum (including transplant ICU)

Full Recovery: 3 to 6 months

Post-Op Medications: Lifelong immunosuppressants required (USD 300 to USD 500 per month)

What is a Heart Transplant?

A heart transplant is a major surgery where a failing heart is replaced with a healthy donor heart from a brain-dead individual. The donor must match blood type and size, and the transplant is performed within 4–6 hours of organ retrieval.

The procedure uses a heart-lung machine and requires a highly skilled multidisciplinary team. It is one of the most complex cardiac surgeries.

Without treatment, end-stage heart failure has a poor survival rate. A successful transplant can extend life by 10–20 years and allow patients to return to an active, near-normal life.

Who Needs a Heart Transplant? (Indications)

A heart transplant is considered only when all other treatments have failed and the heart can no longer pump effectively. Common conditions include:

  • End-stage heart failure (very low ejection fraction despite treatment)
  • Dilated cardiomyopathy (DCM)
  • Ischaemic cardiomyopathy (damage from severe coronary artery disease/heart attacks)
  • Hypertrophic cardiomyopathy not responding to treatment
  • Complex congenital heart disease
  • Severe valvular heart disease not repairable
  • Life-threatening arrhythmias unresponsive to other therapies
  • Failed previous cardiac surgeries

Final eligibility is decided by a multidisciplinary transplant team after detailed evaluation. Not all patients qualify—candidates must also be fit enough to undergo surgery and lifelong post-transplant care.

Who is Not Eligible for a Heart Transplant?

Certain conditions may exclude a patient from heart transplant listing. These are known as contraindications and are assessed on a case-by-case basis:

  • Active or recently treated malignancy (cancer) within the last 5 years
  • Severe irreversible kidney, liver, or lung disease that would not improve after transplant
  • Severe pulmonary hypertension (high blood pressure in the lungs) that is fixed and irreversible
  • Active systemic infection including untreated HIV, hepatitis B or C with active disease
  • Ongoing substance abuse including alcohol, tobacco, or recreational drugs
  • Severe, uncontrolled psychiatric illness that would impair medication adherence
  • Age above 65 to 70 years (varies by centre and individual clinical assessment)

Many of these contraindications are relative rather than absolute. Your transplant cardiologist will assess your full clinical picture before any decision is made.

Types of Heart Transplants Available in India

Type Description Best For Availability in India
Orthotopic Heart Transplant The diseased heart is completely removed and replaced with a healthy donor heart in the same anatomical position. Most common technique worldwide. End-stage heart failure, cardiomyopathy, severe coronary disease Available at all major transplant centres
Heterotopic Heart Transplant The donor heart is placed alongside the patient’s own heart. Both hearts function together. Rarely performed. Patients with high pulmonary pressure or size mismatch Available at select advanced centres
Paediatric Heart Transplant Performed on infants, children, and adolescents with congenital heart disease or severe cardiomyopathy. Requires specialised paediatric cardiac teams. Children with congenital defects or paediatric cardiomyopathy Apollo Chennai, Fortis Escorts Delhi, and select centres

The Donor Process and Waiting List in India

Understanding how donor hearts are allocated in India is essential for international patients planning a heart transplant here.

Who Donates Hearts in India?

In India, all heart transplants are performed using hearts from deceased donors who have been formally declared brain-dead. Living donor heart transplants are not possible. The donor’s family must give consent for organ donation. Organ donation after brain death in India is governed by the Transplantation of Human Organs and Tissues Act (THOTA), which ensures strict ethical standards and legal oversight.

How is a Donor Heart Allocated?

The National Organ and Tissue Transplant Organisation (NOTTO), established in 2014, oversees organ procurement and allocation at the national level. State-level organisations including TRANSTAN in Tamil Nadu, Jeevandan in Telangana, and Zonal Transplant Coordination Centres in other states coordinate within their regions. Hearts are allocated based on:

  • Blood group compatibility between donor and recipient
  • Donor and recipient body size compatibility
  • Medical urgency (Priority 1: emergency, Priority 2: semi-urgent, Priority 3: elective)
  • Time on the waiting list at each priority level
  • Geographic proximity, as the donor heart must be transplanted within 4 to 6 hours of harvest

How Long is the Waiting Time?

The waiting time for a donor heart in India varies significantly. Patients listed as Priority 1 (on mechanical circulatory support or in ICU) are given the highest urgency. Waiting times can range from a few weeks to several months depending on blood group, body size, geographic location, and donor availability. Donor availability in South India, particularly Tamil Nadu, is relatively higher due to more established organ donation culture in the region. Many top transplant centres in Chennai receive donor hearts frequently.

Can International Patients be Listed for Transplant in India?

Yes, international patients can be listed for a heart transplant in India. However, they must undergo the full pre-transplant evaluation at an approved transplant centre, be formally accepted by the transplant committee, and comply with all Indian transplant regulations including those of NOTTO. International patients are generally placed on the same waiting list as Indian patients under the applicable priority system. Shifam Health coordinates all aspects of this process with our partner transplant centres.

Pre-Transplant Evaluation: What Does It Involve?

Before a patient can be listed for a heart transplant, they must undergo a thorough evaluation conducted by the transplant team. This evaluation typically takes 5 to 10 days and involves:

Cardiac Investigations

  • Right heart catheterisation to measure pulmonary artery pressures and assess suitability for transplant
  • Left heart catheterisation and coronary angiography
  • Echocardiogram to assess heart structure and function
  • Cardiopulmonary exercise test (VO2 max) to measure functional capacity
  • 24-hour Holter monitoring for rhythm assessment

General Health Investigations

  • Full blood panel including kidney, liver, thyroid, and coagulation function
  • Blood group and crossmatch for donor matching
  • HLA (Human Leukocyte Antigen) tissue typing for immunological compatibility
  • Screening for infections including HIV, hepatitis B and C, tuberculosis, CMV, and EBV
  • CT scan of chest and abdomen
  • Pulmonary function tests
  • Bone density scan (as lifelong steroids affect bones)

Specialist Assessments

  • Transplant cardiologist and cardiac surgeon consultation
  • Anaesthesiology pre-assessment
  • Nutritional assessment
  • Psychological and psychiatric evaluation
  • Social work assessment to confirm medication adherence and support network
  • Transplant coordinator consultation and education session

The Heart Transplant Procedure: Step-by-Step

Here is what happens from the moment a suitable donor heart is identified:

  1. Donor Notification and Preparation: When a suitable donor heart is identified, the transplant team is immediately notified. The recipient is called to the hospital and prepared for surgery. Anaesthesia and pre-operative medications are administered.
  2. Simultaneous Donor and Recipient Surgery: Two surgical teams work simultaneously. One team harvests the donor heart at the donor hospital while the second team begins opening the recipient’s chest at the transplant centre, carefully coordinating timing.
  3. Cardiopulmonary Bypass: The recipient is connected to a heart-lung bypass machine, which takes over the function of the heart and lungs, maintaining circulation and oxygenation while the diseased heart is removed.
  4. Removal of the Diseased Heart: The recipient’s failing heart is surgically removed, leaving behind portions of the atria (upper chambers) and major blood vessels as attachment points for the donor heart.
  5. Implantation of the Donor Heart: The donor heart is carefully sutured into position. The surgical connections include the atria, aorta, and pulmonary artery. The entire implantation is performed with the donor heart cooled in a preservation solution.
  6. Restarting the Heart: Once all surgical connections are complete and verified, the heart-lung machine is gradually weaned off. In most cases, the donor heart restarts spontaneously as blood flow is restored. Electrical cardioversion may be used if needed.
  7. Closure and ICU Transfer: The chest is closed, drainage tubes are placed, and the patient is transferred to the cardiac transplant ICU where they are monitored continuously. Most patients are on a ventilator for 12 to 48 hours post-surgery.

Total surgery duration: 4 to 8 hours, depending on the complexity of the recipient’s anatomy, previous surgeries, and any intra-operative findings.

Risks and Complications of Heart Transplant

A heart transplant carries significant risks. Understanding them honestly is important for patients and families. India’s top transplant centres have robust systems in place to detect and manage these early:

Early Post-Transplant Risks (First 30 Days)

  • Primary Graft Dysfunction: The donor heart fails to function adequately immediately after transplantation. The most serious early complication, requiring ECMO or mechanical support. Managed in specialist transplant ICUs.
  • Acute Rejection: The recipient’s immune system attacks the donor heart. Detected by endomyocardial biopsy and managed with high-dose immunosuppression.
  • Infection: Immunosuppressant medications lower the body’s ability to fight infection. Bacterial, viral (especially CMV), and fungal infections are significant risks in the early post-transplant period.
  • Bleeding and re-exploration: Significant bleeding may require return to the operating theatre in the early post-operative period.

Long-Term Risks

  • Chronic Rejection (Cardiac Allograft Vasculopathy): Gradual narrowing of the coronary arteries of the donor heart due to chronic immune-mediated injury. The leading cause of death after the first year of transplant.
  • Side effects of immunosuppressants: Kidney damage (nephrotoxicity), high blood pressure, diabetes, bone thinning, and increased risk of certain cancers including lymphoma
  • Post-transplant malignancy: Long-term immunosuppression carries a moderately elevated risk of skin cancers and lymphoma
  • Kidney failure: Long-term calcineurin inhibitor use can damage kidney function; some patients eventually require dialysis or kidney transplant

How Top Indian Transplant Centres Minimise Risks

  • Protocol-driven immunosuppression management by experienced transplant pharmacists and cardiologists
  • Regular surveillance including echocardiograms, coronary angiography, and blood-based immune monitoring
  • Dedicated transplant infectious disease specialists for prevention and early treatment of infections
  • Comprehensive post-transplant rehabilitation and dietetic support
  • 24-hour on-call transplant teams during the critical early post-operative period

Heart Transplant Success Rate in India

Success rates at India’s leading transplant centres are consistently in line with international standards reported by the International Society for Heart and Lung Transplantation (ISHLT):

Time Point Survival Rate (India’s Top Centres) Global Benchmark (ISHLT)
30 Days Post-Transplant ~90% ~90–92%
1 Year Post-Transplant 85–90% 85–88%
5 Years Post-Transplant 70–75% 70–72%
10 Years Post-Transplant 50–60% 50–55%
Long-Term Survivors (15–20 Years) Increasingly documented at high-volume centres Well-established in global registry data

India’s top transplant centres match global survival benchmarks. Apollo Hospitals Chennai has reported a 1-year survival rate of over 90 percent across its transplant programme. Success depends heavily on centre volume, surgical expertise, and the quality of post-transplant immunosuppression management.

Heart Transplant Cost in India (2026)

Heart transplant costs in India are significantly lower than in the USA, UK, or Europe, with the same quality of surgical expertise and post-operative care. Costs vary depending on the hospital, city, complexity of the case, and the duration of ICU and hospital stay.

All-Inclusive Heart Transplant Cost in India by Hospital Tier

Hospital Tier Cost (USD) Cost (INR approx.)
Premier JCI-Accredited Centre (Apollo Chennai, Fortis Escorts Delhi, Medanta Gurugram) $30,000 – $45,000 ₹25 lakh – ₹37 lakh
Leading Private Hospital (NABH accredited) $25,000 – $35,000 ₹20 lakh – ₹29 lakh
Government / Teaching Hospital (AIIMS) $8,000 – $15,000 ₹7 lakh – ₹12 lakh (for eligible patients)

Itemized Cost Breakdown (Premier Private Centre)

Cost Component Estimated Cost (USD)
Pre-transplant Evaluation (10–14 days) $3,000 – $6,000
Surgery Fees (Surgeon, Anaesthesiologist, Perfusionist) $5,000 – $9,000
Operating Theatre, Bypass Machine, Equipment $4,000 – $7,000
Transplant ICU (3–6 weeks) $8,000 – $14,000
Hospital Ward Stay (1–2 weeks post-ICU) $2,000 – $4,000
Immunosuppressant Medications (first 3 months) $2,500 – $5,000
Post-transplant Diagnostics (biopsies, echo, angiogram) $1,500 – $3,000
Donor Organ Procurement & Logistics Included in hospital package
International Patient Coordination (Shifam Health) Included
Total Estimate $30,000 – $45,000

International Cost Comparison – Heart Transplant

Country Average Cost (USD) Waiting Time Savings vs India
India $25,000 – $45,000 Weeks to months Reference
Turkey $50,000 – $80,000 Months Save ~50%
Thailand $60,000 – $90,000 Months Save ~55%
United Kingdom (Private) £100,000 – £200,000 (~$126k–$252k) Long waits Save ~75–82%
United States $1,000,000+ Months to years Save ~95%

Important note: The above estimates are for the transplant itself. Post-transplant lifelong immunosuppressant medications cost approximately USD 300 to USD 500 per month globally.

Recovery Timeline After Heart Transplant

Time Point Survival Rate (India’s Top Centres) Global Benchmark (ISHLT)
30 Days Post-Transplant ~90% ~90–92%
1 Year Post-Transplant 85–90% 85–88%
5 Years Post-Transplant 70–75% 70–72%
10 Years Post-Transplant 50–60% 50–55%
Long-Term Survivors (15–20 Years) Increasingly documented at high-volume centres Well-established in global registry data

Lifelong Post-Transplant Commitments

  • Take immunosuppressant medicines daily without missing doses.
  • Attend all follow-ups and required tests.
  • Follow infection precautions and vaccination guidance.
  • Monitor blood pressure, sugar, kidney function, and cholesterol.
  • Maintain a heart-healthy lifestyle (diet, exercise, no tobacco/alcohol).
  • Keep your transplant summary and medication list with you at all times.

Top Hospitals for Heart Transplant in India

Shifam Health works with India’s most experienced and accredited cardiac transplant centres. The following hospitals have established track records in heart transplantation and comprehensive international patient services:

Apollo Hospitals, Chennai

  • Programme highlights: Over 400 heart transplants performed. Reported 1-year survival rate exceeding 90 percent at this centre.
  • Accreditation: JCI and NABH accredited. Recognised by the International Society for Heart and Lung Transplantation (ISHLT).
  • Key specialist: Dr. K.R. Balakrishnan, pioneer of India’s largest heart transplant programme with over 250 heart transplants and LVAD implantations.
  • Dedicated advanced heart failure and transplant unit with ECMO and LVAD capability
  • Strong international patient department with multilingual support in Arabic, French, and Swahili

Fortis Escorts Heart Institute, New Delhi

  • Programme highlights: Among the highest heart transplant volumes in North India. One of very few centres in India with an active LVAD programme.
  • Accreditation: JCI, NABH, and NABL accredited. Repeatedly awarded Best Heart Hospital in India by The Week Magazine.
  • Dedicated paediatric cardiac surgery centre for congenital heart disease transplants in children
  • 5 state-of-the-art catheterization labs and a 24-hour cardiac transplant ICU

Medanta – The Medicity, Gurugram

  • Programme highlights: One of India’s largest quaternary care hospitals with a dedicated Institute of Heart and Vascular Diseases led by Dr. Naresh Trehan, Padma Bhushan awardee.
  • Accreditation: JCI accredited. Founded by internationally trained cardiac surgeons with deep experience in complex transplant cases.
  • Advanced cardiac ICU with ECMO, LVAD, and IABP support for the highest-risk transplant patients

Gleneagles Global Health City, Chennai (Formerly Fortis Malar)

  • Programme highlights: Performed the first successful heart transplant in private sector India in 2008, with a reported success rate of over 95 percent.
  • Dedicated multi-organ transplant centre with specialised cardiac, lung, and liver transplant capabilities
  • Well-established international patient programme with patients from across East Africa and the Middle East

Why Choose India for Your Heart Transplant?

  • Outstanding Cost Savings: India costs 60 to 95 percent less than the USA or UK for the same procedure using the same immunosuppressant protocols and internationally approved devices
  • Globally Competitive Success Rates: Leading Indian centres achieve 85 to 90 percent one-year survival, matching published ISHLT global registry benchmarks
  • Internationally Trained Transplant Surgeons: India’s top transplant surgeons have trained at institutions in the USA, UK, and Europe and have performed hundreds of transplants each
  • JCI Accredited Hospitals: The same international quality standard as leading hospitals in the USA and UK, giving international patients verified safety assurance
  • Active NOTTO Registry: India’s national organ allocation system ensures ethical, transparent, and legally compliant donor matching with clear priority guidelines
  • Affordable Post-Transplant Medications: Immunosuppressant medications that cost USD 2,000 to USD 3,000 per month in the USA can be sourced in India for USD 100 to USD 250 per month through legitimate generic manufacturers under full WHO GMP standards
  • Comprehensive International Patient Infrastructure: Visa letters, airport pickup, multilingual coordinators, accommodation booking, and discharge planning are all available through Shifam Health and our hospital partners

How Shifam Health Helps You Access Heart Transplant Care in India

A heart transplant is the most complex medical journey any patient can undertake. At Shifam Health, we understand that the stakes could not be higher. Our end-to-end support is specifically designed to ensure that international patients access the right hospital, the right transplant team, and the right care, with full transparency and personal support at every step.

1: Case Review
Share your reports. Our partner transplant specialists assess your eligibility and recommend suitable centers free of charge.

2: Hospital & Team Matching
We match you with the most appropriate accredited transplant centre and experienced team based on your condition.

3: Pre-Transplant Evaluation
We organize your full evaluation (5–10 days), including tests, consultations, and clear guidance at each step.

4: Visa & Travel Support
We assist with your medical visa, hospital invitation letter, airport transfers, and accommodation arrangements.

5: On-Ground Support
We stay in close contact throughout your treatment, helping with coordination, communication, and logistics.

6: Discharge & Follow-Up
We ensure you leave with a complete plan, medications, and ongoing support, including connection with a local cardiologist.

Frequently Asked Questions (FAQs)

How much does a heart transplant cost in India?

The all-inclusive cost ranges from USD 25,000 to USD 45,000 at premier JCI-accredited centers. This covers evaluation, surgery, ICU, hospital stay, and initial post-transplant medications. Costs vary by hospital and case complexity. Shifam Health provides a personalized written estimate free of charge.

What is the success rate of heart transplant in India?

India’s leading transplant centers report 85 to 90 percent one-year survival rates, matching global ISHLT benchmarks. Apollo Chennai has reported over 90 percent at one year.

How long do I need to stay in India after a heart transplant?

A minimum stay of 6 to 8 weeks is essential for early post-transplant monitoring, medication adjustment, and management of any early complications before it is safe to return home.

Can international patients be listed for a donor heart in India?

Yes. International patients can be listed under NOTTO regulations after completing the full pre-transplant evaluation at an approved Indian transplant center. Allocation follows the same blood group, size, and urgency criteria applied to all patients.

Will I need to take medications for life after a heart transplant?

Yes. Lifelong immunosuppressant therapy is mandatory to prevent rejection. These typically include tacrolimus, mycophenolate mofetil, and low-dose prednisolone. In India, generic equivalents are available at USD 100 to USD 250 per month compared to USD 2,000 or more in the USA.

Is a heart transplant available for children in India?

Yes. Pediatric heart transplants are available at specialist centers including Apollo Chennai, Fortis Escorts Delhi, and KIMS Chennai.

Conclusion

A heart transplant is a life-changing, life-saving procedure. For patients with end-stage heart failure, it is often the only path forward. India has established itself as a globally trusted destination for cardiac transplantation, combining world-class surgical expertise, modern transplant infrastructure, ethical donor processes, and costs that make this procedure accessible to international patients who would otherwise face insurmountable financial barriers.

Shifam Health is here to guide you through every stage of this journey, from your first consultation to your safe return home with a healthy, functioning donor heart and a complete long-term care plan.

Your heart cannot wait. Reach out to Shifam Health today.

Quick Inquiry Form

Popular Posts From Last Week